Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5292]

FDA approves daratumumab and hyaluronidase-fihj for multiple myeloma

FDA approves daratumumab and hyaluronidase-fihj for multiple myeloma

FDA approves niraparib for first-line maintenance of advanced ovarian cancer

FDA approves niraparib for first-line maintenance of advanced ovarian cancer

Positive topline results from pivotal phase 3 CheckMate -9ER trial evaluating nivolumab in combination with cabozantinib in previously untreated advanced renal cell carcinoma

Positive topline results from pivotal phase 3 CheckMate -9ER trial evaluating nivolumab in combination with...

Researchers' method holds promise for brain study, better tests for viruses and brain cancer

Researchers' method holds promise for brain study, better tests for viruses and brain cancer

AACR 2020: Study shows immunotherapy prior to surgery may help destroy high-risk breast cancer

AACR 2020: Study shows immunotherapy prior to surgery may help destroy high-risk breast cancer

Major trial shows breast cancer drug can hit prostate cancer Achilles heel

Major trial shows breast cancer drug can hit prostate cancer Achilles heel

AACR 2020: Study finds no overall survival benefit, but improved quality of life with talazoparib in advanced BRCA-mutated breast cancer

AACR 2020: Study finds no overall survival benefit, but improved quality of life with talazoparib in advanced BRCA...

Immune system changes occur early in development of multiple myeloma, study finds

Immune system changes occur early in development of multiple myeloma, study finds

Pancreatic cancer cells hijack basic cell mechanism to evade immunotherapy

Pancreatic cancer cells hijack basic cell mechanism to evade immunotherapy

The physiological mechanisms underlying the most common paediatric leukaemia discovered

The physiological mechanisms underlying the most common paediatric leukaemia discovered

More from ecancer